We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

27 hedge funds and large institutions have $86.2M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
+$11.7M
2
FTCM
Fir Tree Capital Management
New York
+$9.76M
3
MI
MMCAP International
Cayman Islands
+$7.81M
4
SCC
Spring Creek Capital
Kansas
+$7.81M
5
ACA
Arena Capital Advisors
California
+$5.86M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
26
Wolverine Asset Management
Illinois
$6K +$6.89K +706 New
UBS Group
27
UBS Group
Switzerland
– +$127 +13 New
1
2

ORIA Hedge Fund Activity: Q3 2021 in Review

27 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q3 2021, worth a combined $86.2M.

Buyers outnumbered sellers: 27 funds opened new ORIA positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $11.7M.

  • 27 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $86.2M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q3 2021.
  • 27 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q3 2021 and 0 closed out, a net change of +27 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q3 2021 was 683 Capital Management, an estimated $11.7M added.

Based on aggregated 13F filings for Q3 2021.